| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/22/2010 | WO2010045370A2 Method of preparing polyglutamate conjugates |
| 04/22/2010 | WO2010045321A2 Pegylation of recombinant blood coagulation factors in the presence of bound antibodies |
| 04/22/2010 | WO2010045292A2 Nanoparticle compositions comprising liquid oil cores |
| 04/22/2010 | WO2010045281A2 Stable aqueous formulations of water insoluble or poorly soluble drugs |
| 04/22/2010 | WO2010045225A1 Induction of mucosal immune responses by mucosal delivery pentabody complex (mdpc) |
| 04/22/2010 | WO2010045209A2 Methods of treating pulmonary disorders with liposomal amikacin formulations |
| 04/22/2010 | WO2010044867A1 Highly concentrated drug particles, formulations, suspensions and uses thereof |
| 04/22/2010 | WO2010044597A2 Drug delivery device |
| 04/22/2010 | WO2010044390A1 Viral infection therapeutic drug containing polyalkyleneimine |
| 04/22/2010 | WO2010044089A1 Drug delivery system for econazole, moxifloxacin, and rifampicin |
| 04/22/2010 | WO2010043972A2 Pharmaceutical compositions and methods of use for the prevention and treatment of hypoxic injury |
| 04/22/2010 | WO2010043444A2 Pharmaceutical preparation for the treatment and/or prevention of ischemia/reperfusion injury and the sequels thereof |
| 04/22/2010 | WO2010043156A1 Drop pill for treating coronary heart disease and preparation thereof |
| 04/22/2010 | WO2010043153A1 Fusion protein inhibiting osteoclast formation, preparation method and drug compositions thereof |
| 04/22/2010 | WO2010043106A1 Injectable in-situ crosslinked hydrogel and the preparation method and use thereof |
| 04/22/2010 | WO2010043049A1 Etoposide and doxorubicin conjugates for drug delivery |
| 04/22/2010 | WO2010043047A1 Conjugates of glp-1 agonists and uses thereof |
| 04/22/2010 | WO2010014708A3 Factor viii polymer conjugates |
| 04/22/2010 | WO2010014176A3 Preparation method of biodegradable micro-particles containing drugs |
| 04/22/2010 | WO2010014172A3 Delivery particle |
| 04/22/2010 | WO2010011319A8 Magnetic heating for drug delivery and other applications |
| 04/22/2010 | WO2010009111A3 A drug depot implantable within a synovial joint |
| 04/22/2010 | WO2010005726A3 Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same |
| 04/22/2010 | WO2010005725A3 Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same |
| 04/22/2010 | WO2010005580A3 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 04/22/2010 | WO2009154978A3 Self-preserved emulsions |
| 04/22/2010 | WO2009148245A4 Novel niacin and hmg-coa reductase inhibitor combination formulation |
| 04/22/2010 | WO2009130602A9 Factor ix conjugates with extended half-lives |
| 04/22/2010 | WO2009129491A4 Beta adrenergic receptor agonists for treatment of pain and/or inflammation |
| 04/22/2010 | WO2009128918A8 Combination therapy using a soluble hyaluronidase and a bisphosphonate |
| 04/22/2010 | WO2009034558A3 Rhein or diacerein compositions |
| 04/22/2010 | WO2009027706A3 Radiolabeled monomeric and multimeric cyclic oligopeptides binding to the cxcr4 receptor for cancer imaging and treatment |
| 04/22/2010 | WO2008047241A3 Modified corticotropin releasing factor peptides and uses thereof |
| 04/22/2010 | US20100100975 Silk proteins |
| 04/22/2010 | US20100099779 Biocompatible material composition adaptable to diverse therapeutic indications |
| 04/22/2010 | US20100099771 Use of cooling agents to relieve mild ocular irritation and enhance comfort |
| 04/22/2010 | US20100099696 Tamper resistant oral dosage forms containing an embolizing agent |
| 04/22/2010 | US20100099655 Implants and methods for treating inflammation-mediated conditions of the eye |
| 04/22/2010 | US20100099647 Aqueous Iron Carbohydrate Complexes, Their Production And Medicaments Containing Them |
| 04/22/2010 | US20100099644 Hpma - docetaxel or gemcitabine conjugates and uses therefore |
| 04/22/2010 | US20100099621 Disodium salts, monohydrates, and ethanol solvates for delivering active agents |
| 04/22/2010 | US20100098765 Powder Makeup Compositions And Methods |
| 04/22/2010 | US20100098761 Polymer Compositions For Biomedical And Material Applications |
| 04/22/2010 | US20100098748 Arg-Gly-Asp (RGD) Sequence Containing Cyclic Peptide and Its Active Targeting Liposomes |
| 04/22/2010 | US20100098680 Anti-pathogen treatments |
| 04/22/2010 | US20100098656 Polyamino acids functionalized by hydrophobic grafts bearing an anionic charge and applications thereof, such as therapeutic applications |
| 04/22/2010 | US20100098653 Antioxidant polymers containing [1,2]-dithiolane moieties and uses thereof |
| 04/22/2010 | US20100098649 Polymer conjugates for a controlled release of active molecules |
| 04/22/2010 | US20100098647 Soap-Based Liquid Wash Formulations with Enhanced Deposition of Make-Up Agents |
| 04/22/2010 | US20100098646 Soap-Based Liquid Wash Formulations with Enhanced Deposition of Conditioning and/or Skin Appearance Enhancing Agents |
| 04/22/2010 | US20100098642 Optimised formulation of tobramycin for aerosolization |
| 04/22/2010 | US20100098625 Icbp90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
| 04/22/2010 | US20100095963 Pharmaceutical compositions |
| 04/22/2010 | DE202004021680U1 Feste pharmazeutische Zusammensetzung A solid pharmaceutical composition |
| 04/22/2010 | CA2822167A1 Pharmaceutical topical compositions |
| 04/22/2010 | CA2740716A1 Induction of mucosal immune responses by mucosal delivery pentabody complex (mdpc) |
| 04/22/2010 | CA2740317A1 Etoposide and doxorubicin conjugates for drug delivery |
| 04/22/2010 | CA2740316A1 Conjugates of glp-1 agonists and uses thereof |
| 04/22/2010 | CA2740136A1 Injectable in-situ crosslinked hydrogel and methods of making and using thereof |
| 04/22/2010 | CA2739954A1 Methods of treating pulmonary disorders with liposomal amikacin formulations |
| 04/22/2010 | CA2739291A1 Method of preparing polyglutamate conjugates |
| 04/22/2010 | CA2738757A1 Pharmaceutical compositions and methods of use for the prevention and treatment of hypoxic injury |
| 04/22/2010 | CA2738715A1 Highly concentrated drug particles, formulations, suspensions and uses thereof |
| 04/22/2010 | CA2738679A1 Modified blood factors comprising a low degree of water soluble polymer |
| 04/22/2010 | CA2738614A1 Drop pill for treating coronary heart disease and preparation thereof |
| 04/22/2010 | CA2738064A1 Pegylation of recombinant blood coagulation factors in the presence of bound antibodies |
| 04/21/2010 | EP2177620A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/21/2010 | EP2177601A1 Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance |
| 04/21/2010 | EP2177539A1 Propylene glycol hyaluronate ester and external preparation for skin using the same |
| 04/21/2010 | EP2177531A2 Cell permeable peptide |
| 04/21/2010 | EP2177230A1 Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor |
| 04/21/2010 | EP2177212A1 Methods of using lamellar bodies for therapeutic purposes |
| 04/21/2010 | EP2176301A1 Aqueous polymer dispersion based on n,n-diethylaminoethyl methacrylate, its preparation and use |
| 04/21/2010 | EP2176296A1 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 04/21/2010 | EP2176295A1 Humanized anti-cd79b antibodies and immunoconjugates and methods of use |
| 04/21/2010 | EP2176245A2 Lipid conjugated cyclic carbonate derivatives, their synthesis, and uses |
| 04/21/2010 | EP2175935A2 Topical composition containing adapalene for the treatment of keratinization disorders |
| 04/21/2010 | EP2175887A1 Compositions for delivery of therapeutics and other materials |
| 04/21/2010 | EP2175841A1 Osteopontin nanoparticles system for drug delivery |
| 04/21/2010 | EP2175837A2 Micro-particles, blood-substitute and method for forming same |
| 04/21/2010 | EP2175834A2 Glp-1-fc fusion protein formulation |
| 04/21/2010 | EP2175718A1 Body fluid expanders comprising n-substituted aminosulfonic acid buffers |
| 04/21/2010 | EP1833904B1 Water-dispersible xanthan gum containing composition |
| 04/21/2010 | EP1730174B1 Peptide carrier for drug delivery |
| 04/21/2010 | EP1667732B1 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 04/21/2010 | EP1471887B1 Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 04/21/2010 | EP1392256B1 Improved transdermal therapeutic system for the treatment of parkinson's disease |
| 04/21/2010 | CN1879656B Solid water soluble propolis composition and preparation method thereof |
| 04/21/2010 | CN1787810B Cladribine formulations for improved oral and transmucosal delivery |
| 04/21/2010 | CN1761462B Patch containing nonsteroidal antiinflammatory and analgesic agent |
| 04/21/2010 | CN1514725B Pharmaceutical composition comprising lipase inhibitor and sucrose fatty acid ester |
| 04/21/2010 | CN1450890B Novel compositions of minoxidil |
| 04/21/2010 | CN1343128B Medicinal compositions |
| 04/21/2010 | CN101696278A Preparation method of water soluble self-assembly chitosan nano-particles and application of chitosan nano-particles |
| 04/21/2010 | CN101696270A Hydrophilic polymer of resveratrol conjugate and preparing method thereof |
| 04/21/2010 | CN101696267A Photosensitive and targeting-functionalization polycaprolactone and preparation method thereof |
| 04/21/2010 | CN101696240A Long lasting growth hormone releasing factor derivatives |
| 04/21/2010 | CN101695567A Water-in-oil type nanoemulsion vaccine preparation |
| 04/21/2010 | CN101695512A Banlangen buccal tablet and preparation method thereof |
| 04/21/2010 | CN101695501A Chitosan entrapment body of nano-scale arsenous acid and manufacturing method thereof |